Carmustine for Injection USP In Stock
Brain-Disorder

Carmustine for Injection USP

Carmustine for Injection USP is an anticancer medicine used in the treatment of certain types of cancers by damaging the DNA of cancer cells and slowing their growth.

Product Details

Carmustine for Injection USP is an alkylating antineoplastic medicine used in the treatment of certain cancers, including some brain tumors, multiple myeloma, and lymphomas. It works by damaging the DNA of cancer cells, which interferes with their ability to grow and multiply.

Key Benefits
- Used in the treatment of certain types of cancer
- Helps slow the growth and multiplication of cancer cells
- May be used for certain brain tumors and blood cancers
- Can be used alone or as part of combination cancer treatment
- Supports targeted cancer therapy by interfering with cancer cell DNA
How It Works
Carmustine belongs to the nitrosourea group of alkylating agents. It forms reactive compounds that damage and cross-link DNA and can also interfere with RNA and proteins. This prevents cancer cells from properly reproducing and contributes to their destruction.
Common Side Effects
- Nausea and vomiting
- Loss of appetite
- Weakness or fatigue
- Decreased blood cell counts
- Increased risk of infection
- Increased risk of bleeding
- Headache
Important Information
Carmustine for Injection should be administered only by a qualified healthcare professional experienced in cancer treatment. Regular blood tests are required to monitor blood cell counts because serious and delayed bone marrow suppression can occur. Kidney, liver, and lung function may also require monitoring. Carmustine can cause serious lung toxicity and other severe adverse effects, so treatment should be closely supervised by an oncologist.